Chiral Spiro-PNP Ligand Iridium Catalyst Asymmetric Hydrogenation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current catalytic systems struggle to achieve high enantioselectivity in the asymmetric catalytic hydrogenation of dialkyl ketones, such as methyl ethyl ketone, due to the difficulty in recognizing the chirality of the carbonyl plane of these substrates.
Innovation Solution
The development of chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligands and their iridium catalysts, which incorporate a new phosphorus atom in the chiral spirocyclic amino phosphine ligand, allowing for precise adjustment of steric hindrance around the metal center and enhanced chirality control.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional catalytic systems are used for asymmetric catalytic hydrogenation of dialkyl ketones, then the reaction can proceed under mild conditions, but high enantioselectivity cannot be achieved due to difficulty in recognizing the chirality of the carbonyl plane
Solution Approach 1:
The patent employs chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligands with asymmetric molecular structures that create chiral environments around the iridium metal center. This asymmetry enables the catalyst to distinguish between enantiotopic faces of the carbonyl group, achieving high enantioselectivity (up to 99.8% ee) in the hydrogenation of dialkyl ketones.
Solution Approach 2:
The ligand design incorporates localized chiral spirocyclic units with specific steric hindrance patterns that create distinct chemical environments at different positions around the metal center. This local quality differentiation allows precise recognition of the carbonyl plane chirality and control of the hydrogenation stereochemistry.
2Manufacturing precision
If chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligands with adjusted steric hindrance are used, then enantioselectivity is improved, but the ligand structure and catalyst design become more complex
Solution Approach 1:
The patent merges multiple functional groups (phosphine, nitrogen, and second phosphine) into a single tridentate ligand framework with a chiral spirocyclic core. This integration allows the ligand to provide both chiral recognition and steric control in a unified structure, achieving high enantioselectivity while managing structural complexity through systematic design.
Solution Approach 2:
The patent systematically adjusts steric hindrance parameters by varying substituents on the spirocyclic framework and ligand arms. By optimizing these structural parameters, the catalyst achieves optimal enantioselectivity (up to 99.8% ee) while maintaining reasonable structural complexity and synthesizability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves excellent enantioselectivity (up to 99.8% ee) and high catalytic activity in the asymmetric hydrogenation of dialkyl ketones, surpassing previous challenges in this area.
Implementation Method 1
Using transition metals for asymmetric catalytic hydrogenation has the advantages of high atom economy, mild reaction conditions, high catalytic activity, and good enantioselectivity
Implementation Method 2
asymmetric catalytic hydrogenation of simple dialkyl ketones
Data Source
AI summary
The present invention relates to a preparation method for and an application of a chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand SpiroPNP and an iridium catalyst Ir-SpiroPNP thereof. The chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand is a compound represented by formula I, or a racemate or optical isomer thereof or a catalytically acceptable salt thereof; and the main structural feature is a phosphine ligand having a chiral spiro indene skeleton and a large sterically hindered substituent. The chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand can be synthesized into a chiral starting material from a 7-diaryl/alkylphosphino-7′-amino-1,1′-spirodihydroindenyl compound having a spiro ring skeleton. The iridium catalyst of the chiral spirocyclic phosphino-7′-amino-1,1′-spirodihydroindenyl compound having a spiro ring skeleton. The iridium catalyst of the chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand is a compound represented by formula II, or a racemate or optical isomer thereof, or a catalytically acceptable salt thereof. The iridium catalyst can be used to catalyze the asymmetric catalytic hydrogenation of carbonyl compounds, and especially in the asymmetric catalytic hydrogenation of simple dialkyl ketones. Said catalyst exhibits high yield (>99%) and enantioselectivity (up to 99.8% ee), thus having practical value.